Abstract
Research has been conducted on the chemical and biological properties of combinatorial succinylated derivatives of interferon-γ with various levels of acylation, which create quasi-life, self-organizing ensembles. As a result of the research, it has been established that acylation by succinic anhydride of two lysines in the structure of interferon-γ (Gammaferon) leads to both an increase in its affinity to cell receptors and a decrease in the time of maximum effect from 48 hours to 15 minutes. Moreover, treatment of cells with these interferon ensembles led to the shielding of 100% of the cells after a 15-minute incubation period, whereas native interferon shielded no more than 80% of the cells after 48 hours. Other ensembles also protected cells from viral action, but this protective effect did not exceed two hours in duration. The ensemble of succinylated interferon-γ with two modified lysines may hold promise for the treatment of severe viral infections with fast courses, such as influenza and the diseases caused by the Ebola, Marburg, SARS, and other viruses.
Keywords: Antiviral, biological activity, cell protection, interferon-γ, self-organizing systems, succinylation, supramolecular ensembles, interferon ensembles, Gammaferon, acylation
Current Medicinal Chemistry
Title: Quasi-Life Self-Organizing Systems: Based on Ensembles of Succinylated Derivatives of Interferon-Gamma
Volume: 18 Issue: 22
Author(s): A. Martynov, B. Farber and S. Farber
Affiliation:
Keywords: Antiviral, biological activity, cell protection, interferon-γ, self-organizing systems, succinylation, supramolecular ensembles, interferon ensembles, Gammaferon, acylation
Abstract: Research has been conducted on the chemical and biological properties of combinatorial succinylated derivatives of interferon-γ with various levels of acylation, which create quasi-life, self-organizing ensembles. As a result of the research, it has been established that acylation by succinic anhydride of two lysines in the structure of interferon-γ (Gammaferon) leads to both an increase in its affinity to cell receptors and a decrease in the time of maximum effect from 48 hours to 15 minutes. Moreover, treatment of cells with these interferon ensembles led to the shielding of 100% of the cells after a 15-minute incubation period, whereas native interferon shielded no more than 80% of the cells after 48 hours. Other ensembles also protected cells from viral action, but this protective effect did not exceed two hours in duration. The ensemble of succinylated interferon-γ with two modified lysines may hold promise for the treatment of severe viral infections with fast courses, such as influenza and the diseases caused by the Ebola, Marburg, SARS, and other viruses.
Export Options
About this article
Cite this article as:
Martynov A., Farber B. and Farber S., Quasi-Life Self-Organizing Systems: Based on Ensembles of Succinylated Derivatives of Interferon-Gamma, Current Medicinal Chemistry 2011; 18 (22) . https://dx.doi.org/10.2174/092986711796504574
DOI https://dx.doi.org/10.2174/092986711796504574 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Herbal Based Polymeric Nanoparticles as a Therapeutic Remedy for Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Targeted Delivery of Tumor Suppressor microRNA-1 by Transferrin- Conjugated Lipopolyplex Nanoparticles to Patient-Derived Glioblastoma Stem Cells
Current Pharmaceutical Biotechnology PARP Inhibitors: An Interesting Pathway also for Non-Small Cell Lung Cancer?
Current Pharmaceutical Design Targeting Transcription Factor Binding to DNA by Competing with DNA Binders as an Approach for Controlling Gene Expression
Current Topics in Medicinal Chemistry Immunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry The Role for Oxidative Stress in Aberrant DNA Methylation in Alzheimer’s Disease
Current Alzheimer Research Comparison of Anticancer Properties of Annona muricata L. Acetonic and Methanolic Leaf Extracts
The Natural Products Journal Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo
Current Pharmaceutical Design The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery
Current Cancer Drug Targets The Plasma Levels of hsa-miR-19b-3p, hsa-miR-125b-5p, and hsamiR- 320c in Patients with Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS)
MicroRNA Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor
Combinatorial Chemistry & High Throughput Screening Applications of Muscle Electroporation Gene Therapy
Current Gene Therapy Effects of Diet-Derived Molecules on the Tumor Microenvironment
Current Angiogenesis (Discontinued) Update Clinical Application of Diffusion Tensor Imaging
Current Medical Imaging Editorial [Hot Topic: Target Therapy in Brain Tumours and Metastases (Guest Editors: M. Caraglia and R. Addeo)]
Current Cancer Drug Targets Molecular Aspects of FKBP51 that Enable Melanoma Dissemination
Current Molecular Pharmacology Epidermal Growth Factor Receptors: A Functional Perspective
Current Radiopharmaceuticals Nanoparticles: Properties and Applications in Cancer Immunotherapy
Current Pharmaceutical Design Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery
Current Medicinal Chemistry Anticancer Peptides and Proteins: A Panoramic View
Protein & Peptide Letters